This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Side Effects of risedronate: A Synthesis of Findings from 29 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of risedronate: A Synthesis of Findings from 29 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Main Research Findings

Risedronate is a bisphosphonate medication commonly used to treat osteoporosis. Multiple studies have demonstrated its effectiveness in reducing fracture risk associated with osteoporosis. 2 It functions by inhibiting bone resorption, leading to increased bone density and a reduced likelihood of fractures. 19 15 11 However, it's important to note that risedronate, like other medications, can cause side effects.

Reasons for Side Effects

Risedronate's mechanism of treating osteoporosis, which involves inhibiting bone resorption, can also affect tissues beyond bone, potentially leading to side effects. 10

Common Side Effects

Gastrointestinal Side Effects

Risedronate can cause gastrointestinal side effects such as stomach pain, esophagitis, and gastric ulcers. 2 13 11 Risedronate is sensitive to gastric acid, increasing the risk of side effects like esophagitis and gastric ulcers, highlighting the importance of careful administration. 25 9

Bone Side Effects

Risedronate use has been linked to bone side effects like osteonecrosis of the jaw. 10 7 Osteonecrosis of the jaw is characterized by jawbone death, presenting with symptoms like pain and swelling. Risedronate can inhibit jawbone regeneration, potentially leading to osteonecrosis. 10

Other Side Effects

Other reported side effects of risedronate include joint pain, muscle pain, fever, and fatigue. 28 5

Measures to Address Side Effects

Measures to Address Gastrointestinal Side Effects

Taking risedronate with milk or water is recommended to protect the stomach. 2 Additionally, avoiding taking it on an empty stomach or immediately before bedtime and taking it right after meals is crucial. 2

Measures to Address Bone Side Effects

Regular dental checkups are essential when taking risedronate. 7 Maintaining good oral hygiene is crucial for preventing osteonecrosis of the jaw. 7

Comparison Across Studies

Commonalities Across Studies

Multiple studies have shown risedronate to be effective in treating osteoporosis. 2 25 19 18 15 27 17 11 16 20 21 Additionally, they consistently indicate that risedronate can cause gastrointestinal side effects and osteonecrosis of the jaw. 2 13 9 7 10

Differences Across Studies

Risedronate's dosing frequency and dosage, as well as the incidence and severity of its effects and side effects, vary across studies. 18 27 11 3 28 14 For instance, some studies suggest that risedronate is more effective when taken once a month rather than once a week. 18 27 It's also used not only to treat osteoporosis but also as a preventative measure for those at high risk of developing it. 17 11 Risedronate is also used for patients with kidney disease. 8

Points to Note When Applying Research to Real Life

Risedronate is a valuable drug for treating osteoporosis, but it does carry the risk of side effects. 2 7 When taking risedronate, always follow your doctor's instructions and avoid stopping or changing your dosage without consulting them. 16 Before taking it, always inform your doctor about any medications you are currently taking, pre-existing conditions, and allergies. 16

Limitations of Current Research

There is still insufficient research on the long-term effects and safety of risedronate. 22 Additionally, the incidence and severity of risedronate's side effects vary between individuals, and not all patients experience them in the same way. 7

Directions for Future Research

Further research is needed on the long-term effects, safety, incidence, and severity of risedronate's side effects. 22 Additionally, there is hope for the development of new therapies and preventative measures to mitigate risedronate's side effects. 26

Conclusion

Risedronate is a valuable drug for treating osteoporosis, but it does carry the risk of side effects. 2 When taking risedronate, always follow your doctor's instructions and avoid stopping or changing your dosage without consulting them. 16 Before taking it, always inform your doctor about any medications you are currently taking, pre-existing conditions, and allergies. 16 Osteoporosis, if left untreated, increases the risk of fractures. 2 Treating osteoporosis requires appropriate drug therapy and lifestyle changes. 25


Keywords
Benefit Keywords
Bisphosphonate therapy
Bisphosphonate treatment
Bone Disease Treatment
Bone disease treatment
Bone health
Bone health improvement
CIO
CIO treatment
Corticosteroid-induced osteoporosis
Corticosteroid-induced osteoporosis treatment
Effective
Effective Paget's disease treatment
Effective Paget's treatment
Effective antiresorptive
Effective antiresorptive agent
Effective antiresorptive agents
Effective for CIO
Effective for PMO
Effective for Paget's disease
Effective for corticosteroid-induced osteoporosis
Effective for osteoporosis
Effective for postmenopausal osteoporosis
Effective osteoporosis treatment
Effective therapy
Effective treatment
Effective treatment for CIO
Effective treatment for PMO
Effective treatment for Paget's disease
Effective treatment for corticosteroid-induced osteoporosis
Effective treatment for postmenopausal osteoporosis
Effective treatment of CIO
Effective treatment of PMO
Effective treatment of Paget's disease
Improve bone health
Improved Paget's disease
Improved bone health
Improved osteoporosis
Improved quality of life
Osteoporosis
Osteoporosis treatment
PMO
PMO treatment
Paget's disease
Paget's disease treatment
Paget's treatment
Postmenopausal osteoporosis
Postmenopausal osteoporosis treatment
Reduce bone resorption
Reduced Paget's disease
Reduced bone resorption
Reduced fractures
Reduced osteoporosis
Reduced osteoporosis risk
Reduced osteoporosis severity
Reduced pain
Reduced side effects
Risedronate
Risedronate Paget's disease treatment
Risedronate bone disease treatment
Risedronate effective
Risedronate effective for CIO
Risedronate effective for PMO
Risedronate effective for Paget's disease
Risedronate effective for osteoporosis
Risedronate effectiveness
Risedronate efficacy
Risedronate efficacy for Paget's disease
Risedronate for CIO
Risedronate for PMO
Risedronate for Paget's
Risedronate for Paget's disease
Risedronate for corticosteroid-induced osteoporosis
Risedronate for osteoporosis
Risedronate for postmenopausal osteoporosis
Risedronate osteoporosis treatment
Risedronate safety
Risedronate therapy
Risedronate tolerability
Risedronate tolerated
Risedronate treatment
Risedronate treats Paget's disease
Risedronate treats osteoporosis
Risedronate well tolerated for CIO
Risedronate well tolerated for PMO
Risedronate well tolerated for Paget's disease
Risedronate well-tolerated
Short regimen
Short treatment
Short treatment duration
Short treatment regimen
Stronger bones
Sustained remission
Treat Paget's disease
Treat osteoporosis
Treatment of CIO
Treatment of PMO
Treatment of Paget's disease
Treatment of corticosteroid-induced osteoporosis
Treatment of osteoporosis
Treatment of postmenopausal osteoporosis
Treats Paget's disease
Treats bone disease
Treats osteoporosis
Well tolerated
Well-tolerated
Well-tolerated bisphosphonate
Well-tolerated osteoporosis treatment
Well-tolerated therapy
Well-tolerated treatment
effective for Paget's disease
risedronate for Paget's disease
risedronate for corticosteroid-induced osteoporosis
risedronate for postmenopausal osteoporosis
short treatment regimen
well tolerated
19
Alendronate prevents bone loss
Alendronate prevents bone loss and reduces fractures
Bisphosphonates prevent bone loss
Bone Density Increase
Bone density increase
Bone health
Bone loss prevention
Bone loss reduction
Bone mineral density
Bone mineral density increase
Calcitonin increases bone density
Calcitonin increases bone mineral density
Calcium and Vitamin D prevent osteoporosis
Calcium and vitamin D benefit
Calcium and vitamin D prevent osteoporosis
Decrease fracture risk
Decreases fracture risk
Estrogens and raloxifene prevent bone loss
Estrogens prevent bone loss
Fracture prevention
Fracture reduction
Fracture risk reduction
Improved bone density
Improved bone formation
Improved bone health
Improved osteoporosis
Increase bone density
Increase bone formation
Increase bone mineral density
Increased bone density
Increased bone mineral density
Increases bone density
Increases bone mineral density
Osteoporosis Prevention
Osteoporosis prevention
Osteoporosis treatment
Prevent bone loss
Prevent osteoporosis
Prevented bone loss
Prevented osteoporosis
Prevention of osteoporosis
Prevents bone loss
Prevents osteoporosis
Raloxifene prevents bone loss
Raloxifene prevents fractures
Reduce fracture risk
Reduce fractures
Reduced bone loss
Reduced fracture risk
Reduced fractures
Reduced osteoporosis
Reduced osteoporosis risk
Reduced risk of fractures
Reduces fracture risk
Reduces fractures
Risedronate prevents bone loss
Risedronate reduces fractures
Stronger bones
Teriparatide increases bone formation
Treat osteoporosis
Treatment of osteoporosis
Zoledronate increases bone density
Zoledronate increases bone mineral density
25
Risk Keywords
Literature analysis of 29 papers
Positive Content
11
Neutral Content
0
Negative Content
0
Article Type
3
2
0
13
29

Language : German


Language : English


Language : English


Author: TorregrosaJosé Vicente, FusterDavid, PedrosoSofía, DiekmannFritz, CampistolJosep María, RubíSebastià, OppenheimerFederico


Language : English


Language : English


Language : Spanish


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : Croatian


Language : English


Language : English


Author: LicataA A


Bisphosphonate therapy
Bisphosphonate treatment
Bone Disease Treatment
Bone disease treatment
Bone health
Bone health improvement
CIO
CIO treatment
Corticosteroid-induced osteoporosis
Corticosteroid-induced osteoporosis treatment
Effective
Effective Paget's disease treatment
Effective Paget's treatment
Effective antiresorptive
Effective antiresorptive agent
Effective antiresorptive agents
Effective for CIO
Effective for PMO
Effective for Paget's disease
Effective for corticosteroid-induced osteoporosis
Effective for osteoporosis
Effective for postmenopausal osteoporosis
Effective osteoporosis treatment
Effective therapy
Effective treatment
Effective treatment for CIO
Effective treatment for PMO
Effective treatment for Paget's disease
Effective treatment for corticosteroid-induced osteoporosis
Effective treatment for postmenopausal osteoporosis
Effective treatment of CIO
Effective treatment of PMO
Effective treatment of Paget's disease
Improve bone health
Improved Paget's disease
Improved bone health
Improved osteoporosis
Improved quality of life
Osteoporosis
Osteoporosis treatment
PMO
PMO treatment
Paget's disease
Paget's disease treatment
Paget's treatment
Postmenopausal osteoporosis
Postmenopausal osteoporosis treatment
Reduce bone resorption
Reduced Paget's disease
Reduced bone resorption
Reduced fractures
Reduced osteoporosis
Reduced osteoporosis risk
Reduced osteoporosis severity
Reduced pain
Reduced side effects
Risedronate
Risedronate Paget's disease treatment
Risedronate bone disease treatment
Risedronate effective
Risedronate effective for CIO
Risedronate effective for PMO
Risedronate effective for Paget's disease
Risedronate effective for osteoporosis
Risedronate effectiveness
Risedronate efficacy
Risedronate efficacy for Paget's disease
Risedronate for CIO
Risedronate for PMO
Risedronate for Paget's
Risedronate for Paget's disease
Risedronate for corticosteroid-induced osteoporosis
Risedronate for osteoporosis
Risedronate for postmenopausal osteoporosis
Risedronate osteoporosis treatment
Risedronate safety
Risedronate therapy
Risedronate tolerability
Risedronate tolerated
Risedronate treatment
Risedronate treats Paget's disease
Risedronate treats osteoporosis
Risedronate well tolerated for CIO
Risedronate well tolerated for PMO
Risedronate well tolerated for Paget's disease
Risedronate well-tolerated
Short regimen
Short treatment
Short treatment duration
Short treatment regimen
Stronger bones
Sustained remission
Treat Paget's disease
Treat osteoporosis
Treatment of CIO
Treatment of PMO
Treatment of Paget's disease
Treatment of corticosteroid-induced osteoporosis
Treatment of osteoporosis
Treatment of postmenopausal osteoporosis
Treats Paget's disease
Treats bone disease
Treats osteoporosis
Well tolerated
Well-tolerated
Well-tolerated bisphosphonate
Well-tolerated osteoporosis treatment
Well-tolerated therapy
Well-tolerated treatment
effective for Paget's disease
risedronate for Paget's disease
risedronate for corticosteroid-induced osteoporosis
risedronate for postmenopausal osteoporosis
short treatment regimen
well tolerated

Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Author: DoggrellSheila A


Alendronate prevents bone loss
Alendronate prevents bone loss and reduces fractures
Bisphosphonates prevent bone loss
Bone Density Increase
Bone density increase
Bone health
Bone loss prevention
Bone loss reduction
Bone mineral density
Bone mineral density increase
Calcitonin increases bone density
Calcitonin increases bone mineral density
Calcium and Vitamin D prevent osteoporosis
Calcium and vitamin D benefit
Calcium and vitamin D prevent osteoporosis
Decrease fracture risk
Decreases fracture risk
Estrogens and raloxifene prevent bone loss
Estrogens prevent bone loss
Fracture prevention
Fracture reduction
Fracture risk reduction
Improved bone density
Improved bone formation
Improved bone health
Improved osteoporosis
Increase bone density
Increase bone formation
Increase bone mineral density
Increased bone density
Increased bone mineral density
Increases bone density
Increases bone mineral density
Osteoporosis Prevention
Osteoporosis prevention
Osteoporosis treatment
Prevent bone loss
Prevent osteoporosis
Prevented bone loss
Prevented osteoporosis
Prevention of osteoporosis
Prevents bone loss
Prevents osteoporosis
Raloxifene prevents bone loss
Raloxifene prevents fractures
Reduce fracture risk
Reduce fractures
Reduced bone loss
Reduced fracture risk
Reduced fractures
Reduced osteoporosis
Reduced osteoporosis risk
Reduced risk of fractures
Reduces fracture risk
Reduces fractures
Risedronate prevents bone loss
Risedronate reduces fractures
Stronger bones
Teriparatide increases bone formation
Treat osteoporosis
Treatment of osteoporosis
Zoledronate increases bone density
Zoledronate increases bone mineral density

Language : English


Language : English


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.